340 related articles for article (PubMed ID: 33463049)
21. Prognostic value of innate and adaptive immunity in colorectal cancer.
Grizzi F; Bianchi P; Malesci A; Laghi L
World J Gastroenterol; 2013 Jan; 19(2):174-84. PubMed ID: 23345940
[TBL] [Abstract][Full Text] [Related]
22. Intravascular emboli relates to immunosuppressive tumor microenvironment and predicts prognosis in stage III colorectal cancer.
Song X; Xie D; Tan F; Zhou Y; Li Y; Zhou Z; Pei Q; Pei H
Aging (Albany NY); 2021 Aug; 13(16):20609-20628. PubMed ID: 34438367
[TBL] [Abstract][Full Text] [Related]
23. Characterization of tumor-associated B-cell subsets in patients with colorectal cancer.
Shimabukuro-Vornhagen A; Schlößer HA; Gryschok L; Malcher J; Wennhold K; Garcia-Marquez M; Herbold T; Neuhaus LS; Becker HJ; Fiedler A; Scherwitz P; Koslowsky T; Hake R; Stippel DL; Hölscher AH; Eidt S; Hallek M; Theurich S; von Bergwelt-Baildon MS
Oncotarget; 2014 Jul; 5(13):4651-64. PubMed ID: 25026291
[TBL] [Abstract][Full Text] [Related]
24. Single-cell RNA sequencing reveals distinct cellular factors for response to immunotherapy targeting CD73 and PD-1 in colorectal cancer.
Kim M; Min YK; Jang J; Park H; Lee S; Lee CH
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34253638
[TBL] [Abstract][Full Text] [Related]
25. ST2 and regulatory T cells in the colorectal adenoma/carcinoma microenvironment: implications for diseases progression and prognosis.
Cui G; Yuan A; Li Z; Goll R; Florholmen J
Sci Rep; 2020 Apr; 10(1):5892. PubMed ID: 32246094
[TBL] [Abstract][Full Text] [Related]
26. Large tumor suppressor 2 is a prognostic biomarker and correlated with immune infiltrates in colorectal cancer.
Zhao C; Chen J; Liu Y; Ju S; Wang G; Wang X
Bioengineered; 2021 Dec; 12(2):11648-11661. PubMed ID: 34699318
[TBL] [Abstract][Full Text] [Related]
27. Computational identification and clinical validation of a novel risk signature based on coagulation-related lncRNAs for predicting prognosis, immunotherapy response, and chemosensitivity in colorectal cancer patients.
Zhang F; Zhang R; Zong J; Hou Y; Zhou M; Yan Z; Li T; Gan W; Lv S; Yang L; Zeng Z; Zhao W; Yang M
Front Immunol; 2023; 14():1279789. PubMed ID: 37928532
[TBL] [Abstract][Full Text] [Related]
28. Identification of prognosis-associated immune genes and exploration of immune cell infiltration in colorectal cancer.
Miao YD; Wang JT; Yang Y; Ma XP; Mi DH
Biomark Med; 2020 Oct; 14(14):1353-1369. PubMed ID: 33064017
[No Abstract] [Full Text] [Related]
29. An immune-related gene prognostic index for predicting prognosis in patients with colorectal cancer.
Li C; Wirth U; Schardey J; Ehrlich-Treuenstätt VV; Bazhin AV; Werner J; Kühn F
Front Immunol; 2023; 14():1156488. PubMed ID: 37483596
[TBL] [Abstract][Full Text] [Related]
30. Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer.
Chen H; Yao J; Bao R; Dong Y; Zhang T; Du Y; Wang G; Ni D; Xun Z; Niu X; Ye Y; Li HB
Mol Cancer; 2021 Feb; 20(1):29. PubMed ID: 33557837
[TBL] [Abstract][Full Text] [Related]
31. Increased CD8 Tumor Infiltrating Lymphocytes in Colorectal Cancer Microenvironment Supports an Adaptive Immune Resistance Mechanism of PD-L1 Expression.
Sudoyo AW; Kurniawan AN; Kusumo GD; Putra TP; Rexana FA; Yunus M; Budiyati AD; Kurniawan D; Utama A; Utomo AR
Asian Pac J Cancer Prev; 2019 Nov; 20(11):3421-3427. PubMed ID: 31759368
[TBL] [Abstract][Full Text] [Related]
32. Development of an Immune Infiltration-Related Eight-Gene Prognostic Signature in Colorectal Cancer Microenvironment.
Wu B; Tao L; Yang D; Li W; Xu H; He Q
Biomed Res Int; 2020; 2020():2719739. PubMed ID: 32908876
[TBL] [Abstract][Full Text] [Related]
33. LncRNA SATB2-AS1 inhibits tumor metastasis and affects the tumor immune cell microenvironment in colorectal cancer by regulating SATB2.
Xu M; Xu X; Pan B; Chen X; Lin K; Zeng K; Liu X; Xu T; Sun L; Qin J; He B; Pan Y; Sun H; Wang S
Mol Cancer; 2019 Sep; 18(1):135. PubMed ID: 31492160
[TBL] [Abstract][Full Text] [Related]
34. CAF signature predicts the prognosis of colorectal cancer patients: A retrospective study based on bulk RNA sequencing and single-cell RNA sequencing data.
Liang C; Ji D; Qin F; Chen G
Medicine (Baltimore); 2023 Mar; 102(10):e33149. PubMed ID: 36897717
[TBL] [Abstract][Full Text] [Related]
35. Interleukin 33/ST2 Axis Components Are Associated to Desmoplasia, a Metastasis-Related Factor in Colorectal Cancer.
Landskron G; De la Fuente López M; Dubois-Camacho K; Díaz-Jiménez D; Orellana-Serradell O; Romero D; Sepúlveda SA; Salazar C; Parada-Venegas D; Quera R; Simian D; González MJ; López-Köstner F; Kronberg U; Abedrapo M; Gallegos I; Contreras HR; Peña C; Díaz-Araya G; Roa JC; Hermoso MA
Front Immunol; 2019; 10():1394. PubMed ID: 31281317
[TBL] [Abstract][Full Text] [Related]
36. Prognostic impact of tumour-infiltrating B cells and plasma cells in colorectal cancer.
Berntsson J; Nodin B; Eberhard J; Micke P; Jirström K
Int J Cancer; 2016 Sep; 139(5):1129-39. PubMed ID: 27074317
[TBL] [Abstract][Full Text] [Related]
37. An immune landscape based prognostic signature predicts the immune status and immunotherapeutic responses of patients with colorectal cancer.
Li M; Li W; Yang X; Wang H; Peng Y; Yin J; Lu Y; Liu L; Shang J; Zhao Q
Life Sci; 2020 Nov; 261():118368. PubMed ID: 32888940
[TBL] [Abstract][Full Text] [Related]
38. The acid-sensing ion channel, ASIC2, promotes invasion and metastasis of colorectal cancer under acidosis by activating the calcineurin/NFAT1 axis.
Zhou ZH; Song JW; Li W; Liu X; Cao L; Wan LM; Tan YX; Ji SP; Liang YM; Gong F
J Exp Clin Cancer Res; 2017 Sep; 36(1):130. PubMed ID: 28927426
[TBL] [Abstract][Full Text] [Related]
39. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y
BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687
[TBL] [Abstract][Full Text] [Related]
40. Targeting CD43 optimizes cancer immunotherapy through reinvigorating antitumor immune response in colorectal cancer.
Li YY; Wang XY; Li Y; Wang XM; Liao J; Wang YZ; Hong H; Yi W; Chen J
Cell Oncol (Dordr); 2023 Jun; 46(3):777-791. PubMed ID: 36920728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]